These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28796568)

  • 1. Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis.
    Vora M; Kevil CG; Herrera GA
    Ultrastruct Pathol; 2017; 41(5):358-368. PubMed ID: 28796568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro AL-amyloid formation by rat and human mesangial cells.
    Tagouri YM; Sanders PW; Picken MM; Siegal GP; Kerby JD; Herrera GA
    Lab Invest; 1996 Jan; 74(1):290-302. PubMed ID: 8569193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human choroid plexus is an uniquely involved area of the brain in amyloidosis: a histochemical, immunohistochemical and ultrastructural study.
    Sasaki A; Iijima M; Yokoo H; Shoji M; Nakazato Y
    Brain Res; 1997 May; 755(2):193-201. PubMed ID: 9175887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.
    Keeling J; Teng J; Herrera GA
    Lab Invest; 2004 Oct; 84(10):1322-38. PubMed ID: 15286662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction in mice of human light-chain-associated amyloidosis.
    Solomon A; Weiss DT; Pepys MB
    Am J Pathol; 1992 Mar; 140(3):629-37. PubMed ID: 1546744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains.
    Isaac J; Kerby JD; Russell WJ; Dempsey SC; Sanders PW; Herrera GA
    Amyloid; 1998 Dec; 5(4):238-46. PubMed ID: 10036581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
    Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
    PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.
    Yamaguchi H; Yamazaki T; Lemere CA; Frosch MP; Selkoe DJ
    Am J Pathol; 1992 Jul; 141(1):249-59. PubMed ID: 1632466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Abeta peptides and promotes cerebrovascular amyloid angiopathy.
    Clifford PM; Siu G; Kosciuk M; Levin EC; Venkataraman V; D'Andrea MR; Nagele RG
    Brain Res; 2008 Oct; 1234():158-71. PubMed ID: 18708033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative role of alpha-1-antitrypsin in the disaggregation of amyloid lambda fibrils.
    Eriksson S; Janciauskiene S; Merlini G
    J Intern Med; 1995 Feb; 237(2):143-9. PubMed ID: 7852916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrusion of amyloid fibrils to the extracellular space in experimental mesangial AL-amyloidosis: transmission and scanning electron microscopy studies and correlation with renal biopsy observations.
    Teng J; Turbat-Herrera EA; Herrera GA
    Ultrastruct Pathol; 2014 Apr; 38(2):104-15. PubMed ID: 24460740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
    Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
    Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
    Mazzini G; Ricagno S; Caminito S; Rognoni P; Milani P; Nuvolone M; Basset M; Foli A; Russo R; Merlini G; Palladini G; Lavatelli F
    FEBS J; 2022 Jan; 289(2):494-506. PubMed ID: 34482629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelsolin amyloid angiopathy causes severe disruption of the arterial wall.
    Koskelainen S; Pihlamaa T; Suominen S; Zhao F; Salo T; Risteli J; Baumann M; Kalimo H; Kiuru-Enari S
    APMIS; 2016 Aug; 124(8):639-48. PubMed ID: 27198069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
    Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
    Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M
    BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.